ArticleAntimicrobial agents and chemotherapy1996

In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.

T Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.